AI-Developed Universal Vaccine Shows Promise in Preventing Future Pandemics
Researchers at the University of Cambridge, in collaboration with the biotechnology company DIOSynVax, have developed a 'universal vaccine' using artificial intelligence. This vaccine aims to provide immunity against a wide range of viruses by targeting common features across entire virus families. The vaccine, which has undergone its first human trial, was found to be safe and capable of triggering an immune response. This innovative approach could potentially prevent pandemics by offering broad protection against thousands of viral variants, including Ebola. The vaccine's development marks a significant shift from traditional methods, which rely on antigens from specific virus strains. 
